Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Pachner

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Neurology|November 12, 2003
Measurement of MxA mRNA or protein as a biomarker of IFNbeta bioactivity: detection of antibody-mediated decreased bioactivity (ADB)Andrew R Pachner, Antonio Bertolotto, Florian Deisenhammer
Neurology|February 16, 2006
Multiplex analysis of expression of three IFNbeta-induced genes in antibody-positive MS patientsAndrew R Pachner, Kavitha Narayan, Elena Pak
Journal of Neuroimmunology|October 9, 2007
Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibodyAndrew R Pachner, Jennifer Brady, Kavitha Narayan
Journal of Neurovirology|August 12, 2015
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like responseFrancesca Gilli, Libin Li, Andrew R Pachner
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 6, 2021
Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosisKrista D DiSano, Francesca Gilli, Andrew R Pachner
Frontiers in Immunology|June 25, 2021
Memory B Cells in Multiple Sclerosis: Emerging Players in Disease PathogenesisKrista D DiSano, Francesca Gilli, Andrew R Pachner
Frontiers in Neurology|July 29, 2020
SeXX Matters in Multiple SclerosisFrancesca Gilli, Krista D DiSano, Andrew R Pachner
International Journal of Molecular Sciences|July 14, 2023
The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated SyndromeSteven C Pike, Francesca Gilli, Andrew R Pachner
Fluids and Barriers of the CNS|February 26, 2021
Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on "Chemokine CXCL13 in serum, CSF, and blood-CSF barrier function"Krista D DiSano, Francesca Gilli, Andrew R Pachner
Journal of Visualized Experiments : Jove|December 3, 2016
Measuring Progressive Neurological Disability in a Mouse Model of Multiple SclerosisFrancesca Gilli, Darlene B Royce, Andrew R Pachner
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Neurology|November 12, 2003
Measurement of MxA mRNA or protein as a biomarker of IFNbeta bioactivity: detection of antibody-mediated decreased bioactivity (ADB)Andrew R Pachner, Antonio Bertolotto, Florian Deisenhammer
Neurology|February 16, 2006
Multiplex analysis of expression of three IFNbeta-induced genes in antibody-positive MS patientsAndrew R Pachner, Kavitha Narayan, Elena Pak
Journal of Neuroimmunology|October 9, 2007
Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibodyAndrew R Pachner, Jennifer Brady, Kavitha Narayan
Journal of Neurovirology|August 12, 2015
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like responseFrancesca Gilli, Libin Li, Andrew R Pachner
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 6, 2021
Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosisKrista D DiSano, Francesca Gilli, Andrew R Pachner
Frontiers in Immunology|June 25, 2021
Memory B Cells in Multiple Sclerosis: Emerging Players in Disease PathogenesisKrista D DiSano, Francesca Gilli, Andrew R Pachner
Frontiers in Neurology|July 29, 2020
SeXX Matters in Multiple SclerosisFrancesca Gilli, Krista D DiSano, Andrew R Pachner
International Journal of Molecular Sciences|July 14, 2023
The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated SyndromeSteven C Pike, Francesca Gilli, Andrew R Pachner
Fluids and Barriers of the CNS|February 26, 2021
Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on "Chemokine CXCL13 in serum, CSF, and blood-CSF barrier function"Krista D DiSano, Francesca Gilli, Andrew R Pachner
Journal of Visualized Experiments : Jove|December 3, 2016
Measuring Progressive Neurological Disability in a Mouse Model of Multiple SclerosisFrancesca Gilli, Darlene B Royce, Andrew R Pachner
Pageof 6